Seki, N., Morikawa, K., Makiguchi, T., Tanzawa, S., Shimizu, T., Takata, S., Naoki, K., Takeda, Y., Ishizuka, T., Oya, Y., Kohyama, T., Kaira, K., Kishi, K., Watanabe, S., Suda, T., Yamane, H., Ishihara, M., Kagamu, H., Yoshimura, K., Matsutani, N. (2025). Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations: Heat on Beat randomized phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8633